RETRACTED ARTICLE: Diltiazem-lidocaine combination for the attenuation of cardiovascular responses to tracheal intubation in hypertensive patients

Purpose

Hypertensive patients are prone to haemodynamic changes after laryngoscopy and tracheal intubation. This study was undertaken to compare the efficacy of a combination of diltiazem and lidocaine with that of each drug alone for suppressing the cardiovascular responses to trachéal intubation.

Methods

Sixty hypertensive patients (ASA II), defined as systolic blood pressure > 160 mmHg and/or diastolic blood pressure > 95 mmHg (World Health Organization), undergoing elective surgery received, in a randomized, double-blind manner, 0.3 mg·kg^?1 diltiazem, 1.5 mg·kg^?1 lidocaine, or 0.3 mg·kg^?1 diltiazem plus 1.5 mg·kg^?1 lidocaineiv (n = 20 of each) before the initiation of laryngoscopy. Anaesthesia was induced with 5 mg·kg^?1 thiopentoneiv, and tracheal intubation was facilitated with 2 mg·kg^?1 succinylcholineiv after precurarization with 0.02 mg·kg^?1 vecuroniumiv. Changes in heart rate (HR), mean arterial pressure (MAP) and rate-pressure product (RPP) were measured before and at immediate, 1, 2, 3, 5 and 10 min after tracheal intubation.

Results

The inhibitory effects of diltiazem-lidocaine combination on cardiovascular responses to tracheal intubation was greater than those of diltiazem or lidocaine as a sole medicine (RPP; 10602 ± 1448 (combination)vs 11787 ± 1345 (diltiazem), 15428 ± 1756 (lidocaine), mean ± SD,P < 0.05).

Conclusion

Prophylactic therapy with diltiazem-lidocaine combination is more effective than diltiazem or lidocaine alone for attenuating the cardiovascular changes associated with tracheal intubation in hypertensive patients.